Back to search
FDAFDA · Food and drugs·Recall number Z-0335-2019

Zilver 635 Biliary Stent 5mm x 60mm, Catalog Number: ZIB6-125-5.0-60 Product Usage: The Zilver 518 and 635 Biliary Stents are intended for palliation of malignant neoplasms in the biliary tree.

Published November 7, 2018 · Recall initiated: September 25, 2018

Summary

FDA records medical device Class II recall Z-0335-2019, published November 7, 2018 and initiated September 25, 2018. Recalling firm: Cook Medical Incorporated; Status: Terminated; Reported quantity: 9834 total; Lot: GPN: G32033. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The instruction for use detail, with respect to removal of the delivery system as part of Deployment of the stent is incorrect and the IFU is being corrected to amend the instruction for use detail.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cook Medical Incorporated
Distributor
US Nationwide Distribution in the states of: AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NV NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, and Puerto Rico.
Lot
GPN: G32033
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Zilver 635 Biliary Stent 5mm x 60mm, Catalog Number: ZIB6-125-5.0-60 Product Usage: The Zilver 518 and 635 Biliary Stents are intended for palliation of malignant neoplasms in the biliary tree. recalled?

Yes. FDA published recall Z-0335-2019 on November 7, 2018. Reported hazard: The instruction for use detail, with respect to removal of the delivery system as part of Deployment of the stent is incorrect and the IFU is being corrected to amend the instruction for use detail.

What should I do if I have this product?

Voluntary: Firm initiated · Letter